ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1087

Sex Differences in Clinical Features and Mortality in Gout: A Nationwide Retrospective Cohort Study

HYUNSUE DO1, Kwanyoung Choe2, Min Jung Kim3, Kichul Shin4 and Ki Won Moon5, 1Kangwon national university hospital, Seoul, South Korea, 2Yeongjusi Health Center, Yeongjusi, Republic of Korea, 3Seoul Metropolitan Government Boramae Medical center, Dongjak-gu, Seoul, South Korea, 4Seoul Metropolitan Government- Seoul National University Boramae Medical Center, Seoul, South Korea, 5Kangwon National University hospital, Chuncheon-si, Republic of Korea

Meeting: ACR Convergence 2024

Keywords: gout, Mortality

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with gout have several coexisting conditions that impact mortality. Studies on clinical features and mortality of female patients with gout are limited, as gout is far more prevalent in male patients than in females. We analyzed the differences in clinical manifestations and mortality among Korean patients with gout and compared the causes of death based on sex. Furthermore, we identified the risk factors contributing to overall mortality.

Methods: This study was based on patient data collected from the Korean National Health Insurance Service-National Sample Cohort database. We included individuals aged ≥20 years who were diagnosed with gout and received urate-lowering therapy (ULT). Clinical features and mortality rate were compared according to sex, and multivariate Cox regression was performed to calculate hazard ratio (HR) for overall mortality with covariates.

Results: Female patients were older at the start of ULT (60.40 ± 14.87 vs 51.23 ± 14.59) and had more comorbidities. The most common cause of death among patients with gout was chronic kidney disease; however, the order of common causes of death differed by sex. Multivariate Cox analysis showed age at initiation of ULT (HR: 1.10), current smoking (HR: 1.26), diabetes (HR: 1.37), chronic kidney disease (HR: 1.97), cerebrovascular disease (HR: 1.28), and malignancy (HR: 1.88) as significant risk factors for overall mortality. Overall mortality based on sex in multivariate analysis was not statistically different.

Conclusion: The clinical features and mortality pattern were different between male and female patients with gout, suggesting that treatment strategies for gout should be established differently depending on sex.

Supporting image 1

Table 1. Cox regression analysis of overall mortality in gout patients

Supporting image 2

Table 2. Sex differences in common causes of death in patients with gout


Disclosures: H. DO: None; K. Choe: None; M. Kim: None; K. Shin: None; K. Moon: None.

To cite this abstract in AMA style:

DO H, Choe K, Kim M, Shin K, Moon K. Sex Differences in Clinical Features and Mortality in Gout: A Nationwide Retrospective Cohort Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/sex-differences-in-clinical-features-and-mortality-in-gout-a-nationwide-retrospective-cohort-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-differences-in-clinical-features-and-mortality-in-gout-a-nationwide-retrospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology